More than 150 medical research institutions have signed an agreement designed to harmonize and streamline the institutional review process for multisite studies, the National Institutes of Health announced yesterday. The SMART IRB agreement serves as a model to help investigators adhere to a new NIH policy for multisite studies funded by the agency. “This milestone is a giant step toward a nationwide model for greater efficiency in IRB review, which is critical to getting more treatments to more patients more quickly,” said Christopher Austin, M.D., director of NIH’s National Center for Advancing Translational Sciences.

Related News Articles

Headline
The National Collaborative for Improving the Clinical Learning Environment this week released guidance to help health care system leaders work with clinical…
Headline
First-year enrollment at U.S. medical schools has increased by 28% since 2002, with 22 new schools accounting for nearly 40% of the growth, according to the…
Headline
Physicians and teaching hospitals may review and dispute 2016 payments reported to the Centers for Medicare & Medicaid Services’ Open Payments…
Headline
The Senate today voted 79-18 to pass an omnibus appropriations bill providing discretionary funding for the federal government through Sept. 30, the end…
Headline
The House of Representatives today voted 309-118 to pass a fiscal year 2017 omnibus appropriations bill providing discretionary funding for the federal…
Headline
Reps. Joseph Crowley (D-NY) and Ryan Costello (R-PA) yesterday introduced AHA-supported legislation that would add 15,000 Medicare-funded residency positions…